| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45,908 |
41,226 |
$3.98M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14,392 |
14,217 |
$1.34M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,457 |
10,916 |
$929K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,501 |
2,490 |
$204K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
207 |
193 |
$14K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,640 |
1,567 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
42 |
42 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,756 |
5,129 |
$2K |
| 99215 |
Prolong outpt/office vis |
19 |
19 |
$2K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
34,922 |
30,861 |
$2K |
| 99051 |
|
11,561 |
10,406 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,527 |
3,100 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,234 |
2,088 |
$890.86 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
322 |
315 |
$480.55 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
594 |
298 |
$452.78 |
| 81003 |
|
2,670 |
2,585 |
$404.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
453 |
439 |
$203.99 |
| 71046 |
Radiologic examination, chest; 2 views |
1,042 |
1,011 |
$181.20 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
29 |
27 |
$153.93 |
| 93000 |
|
58 |
55 |
$139.09 |
| 72100 |
|
12 |
12 |
$32.35 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
291 |
269 |
$5.56 |
| 99000 |
|
196 |
193 |
$0.00 |
| A9150 |
Non-prescription drugs |
110 |
104 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
175 |
151 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
208 |
181 |
$0.00 |
| 99441 |
|
36 |
36 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
53 |
53 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
55 |
55 |
$0.00 |
| 81025 |
|
127 |
118 |
$0.00 |
| 99442 |
|
47 |
45 |
$0.00 |